United Asset Strategies’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
United Asset Strategies's IBB Position: Q1 2023 in Review
United Asset Strategies sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 6,927 shares — an estimated $909K sold.
United Asset Strategies first reported a position in IBB in Q4 2017 and held it in 20 quarters. The position peaked at $1.07M in Q1 2019. 866 funds tracked by Wall St. Rank hold IBB as of Q1 2023.
- United Asset Strategies reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
- United Asset Strategies sold 6,927 iShares Biotechnology ETF shares in Q1 2023, an estimated $909K.
- United Asset Strategies first reported a position in iShares Biotechnology ETF in Q4 2017 and held it in 20 quarters.
- United Asset Strategies's iShares Biotechnology ETF position peaked at $1.07M in Q1 2019.
- 866 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.
Based on United Asset Strategies's 13F filing for Q1 2023, filed 25 Apr 2023.